CIK 0001709941 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
BioAge Labs, Inc.
Sign in to watch- Ticker
- BIOA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474721157
- Phone
- 510-806-1445
- Business address
- 5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 219,195 shares at an average $19.75 ($4,329,019)
- 4 Open-market buy Former 10% Owner bought 450,000 shares at $18.00 ($8,100,000)
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 900,000 shares at $18.00 ($16,200,000)
- 4 Open-market buy Director bought 400,000 shares at $18.00 ($7,200,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 666,665 shares at $18.00 ($11,999,970)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · Unregistered share sale
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B4 Offering Prospectus
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
Page 6 of 8 · 157 filings